Clinical Trial Update: Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GPI 1485's effects on erectile function after bilateral nerve-sparing prostatectomy in prostate cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Prostate Cancer

Drugs mentioned

• GPI-1485

Snippet

Sponsor: Eisai Inc. | Conditions: Impotence, Prostate Cancer | Phase 2 | Status: COMPLETED